This site is intended for Healthcare professionals only.

2018 ESC Guidelines for Diagnosis and Management of Syncope


2018 ESC Guidelines for Diagnosis and Management of Syncope

The first ESC Guidelines for the management of syncope were published in 2001, with subsequent versions in 2004 and 2009. In March 2015, the ESC CPG considered that there were enough new data to justify the production of new Guidelines.The Task Force for the diagnosis and management of syncope of the European Society of Cardiology (ESC) has come out with latest 2018 ESC Guidelines for Diagnosis and Management of Syncope.The Guideline has been  published in European Heart Journal.The changes in 2018 Guidelines with respect to previous guidelines is given below in a tabular form.

What is new in the 2018 syncope Guidelines? AA = antiarrhythmic; AF = atrial fibrillation; ARVC = arrhythmogenic right ventricular cardiomyopathy; CSM = carotid sinus massage; ECG = electrocardiogram; ED = emergency department; LVEF = left ventricular ejection fraction; EPS = electrophysiological study; HCM = hypertrophic cardiomyopathy; ICD = implantable cardioverter defibrillator; ILR = implantable loop recorder; OH = orthostatic hypotension; PCM = physical counter-pressure manoeuvres; POTS = postural orthostatic tachycardia syndrome; PPS = psychogenic pseudosyncope; SNRT = sinus node recovery time; SU = syncope unit; SVT = supraventricular tachycardia; VT = ventricular tachycardia.

Key Points :

  1. Syncope is defined as transient loss of consciousness (TLOC) due to cerebral hypoperfusion, characterized by a rapid onset, short duration, and spontaneous complete recovery.
  2. At the time of initial evaluation, clinicians should answer the following key questions:
    • Was the event TLOC?
    • In cases of TLOC, are they of syncopal or nonsyncopal origin?
    • In cases of suspected syncope, is there a clear etiological diagnosis?
    • Is there evidence to suggest a high risk of cardiovascular events or death?
    • Is there a serious underlying cause that can be identified?
    • If the cause is uncertain, what is the risk of a serious outcome?
    • Should the patient be admitted to the hospital?
  3. All patients should undergo a complete history, physical examination (including standing blood pressure measurement), and standard electrocardiogram (ECG). ECG monitoring (in bed or telemetry) should be performed in high-risk patients when there is a suspicion of arrhythmic syncope.
  4. An echocardiogram should be performed when there is previous known heart disease, or data suggestive of structural heart disease or syncope secondary to cardiovascular cause. Carotid sinus massage should be performed in patients >40 years of age with syncope of unknown origin compatible with a reflex mechanism. In addition, tilt testing should be performed in cases where there is suspicion of syncope due to reflex or an orthostatic cause.
  5. Prolonged ECG monitoring (external or implantable) should be performed  in patients with recurrent severe unexplained syncope who have all of the following three features:
    • Clinical or ECG features suggesting arrhythmic syncope.
    • A high probability of recurrence of syncope in a reasonable time.
    • Who may benefit from a specific therapy if a cause for syncope is found.
  6. Electrophysiological study should be performed in patients with unexplained syncope and bifascicular bundle branch block (impending high-degree atrioventricular [AV] block) or suspected tachycardia, and an exercise stress test performed in patients who experience syncope during or shortly after exertion.
  7. All patients with reflex syncope and orthostatic hypotension should have the diagnosis explained, reassured, explained the risk of recurrence, and given advice on how to avoid triggers and situations. These measures are the cornerstone of treatment and have a high impact in reducing the recurrence of syncope.
  8. In patients with severe forms of reflex syncope, one or more of the following additional specific treatments according to the clinical features may be selected:
    • Midodrine or fludrocortisone in young patients with low blood pressure phenotype.
    • Counter-pressure maneuvers (including tilt training if needed) in young patients with prodromes.
    • Implantable loop recorder guided management strategy in selected patients without or with short prodromes.
    • Discontinuation/reduction of hypotensive therapy targeting a systolic blood pressure of 140 mm Hg in older hypertensive patients.
    • Pacemaker implantation in older patients with dominant cardioinhibitory forms.
  9. In patients with orthostatic hypotension, one or more of the following additional specific treatments may be selected according to clinical severity:
    • Education regarding lifestyle maneuvers.
    • Adequate hydration and salt intake.
    • Discontinuation/reduction of hypotensive therapy.
    • Counter-pressure maneuvers.
    • Abdominal binders and/or support stockings.
    • Head-up tilt sleeping.
    • Midodrine or fludrocortisone.
  10. The diagnostic process should be reevaluated and alternative therapies considered if the above rules fail or are not applicable to an individual patient. Even though guidelines are based on the best available scientific evidence, treatment should always be tailored to an individual patient’s need and be patient centered.

For further reference log on to :

https://doi.org/10.1093/eurheartj/ehy037

The following two tabs change content below.
Dr. Kamal Kant Kohli

Dr. Kamal Kant Kohli

A Medical practitioner with a flair for writing medical articles, Dr Kamal Kant Kohli joined Medical Dialogues as an Editor-in-Chief for the Speciality Medical Dialogues. Before Joining Medical Dialogues, he has served as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils of India. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751
Source: with inputs

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted